Kreissig I - Search Results

1

Endophthalmitis after intravitreal injection of triamcinolone acetonide.

Jonas JB, Kreissig I, Degenring RF. Jonas JB, et al. Among authors: kreissig i. Arch Ophthalmol. 2003 Nov;121(11):1663-4. doi: 10.1001/archopht.121.11.1663-b. Arch Ophthalmol. 2003. PMID: 14609940 No abstract available.

2

Intravitreal triamcinolone acetonide for treatment of central retinal vein occlusion.

Jonas JB, Akkoyun I, Kamppeter B, Kreissig I, Degenring RF. Jonas JB, et al. Among authors: kreissig i. Eur J Ophthalmol. 2005 Nov-Dec;15(6):751-8. doi: 10.1177/112067210501500615. Eur J Ophthalmol. 2005. PMID: 16329061 Clinical Trial.

3

Cataract surgery combined with intravitreal injection of triamcinolone acetonide.

Jonas JB, Kreissig I, Budde WM, Degenring RF. Jonas JB, et al. Among authors: kreissig i. Eur J Ophthalmol. 2005 May-Jun;15(3):329-35. doi: 10.1177/112067210501500303. Eur J Ophthalmol. 2005. PMID: 15945000 Clinical Trial.

4

[Intravitreal triamcinolone acetonide Complication of infectious and sterile endophthalmitis].

Kreissig I, Degenring RF, Jonas JB. Kreissig I, et al. Ophthalmologe. 2006 Jan;103(1):30-4. doi: 10.1007/s00347-005-1235-1. Ophthalmologe. 2006. PMID: 15915332 Clinical Trial. German.

5

Diffuse diabetic macular oedema treated by intravitreal triamcinolone acetonide: a comparative, non-randomised study.

Jonas JB, Akkoyun I, Kreissig I, Degenring RF. Jonas JB, et al. Among authors: kreissig i. Br J Ophthalmol. 2005 Mar;89(3):321-6. doi: 10.1136/bjo.2004.046391. Br J Ophthalmol. 2005. PMID: 15722313 Free PMC article. Clinical Trial.

6

Repeated intravitreal injection of triamcinolone acetonide for diffuse diabetic macular oedema.

Jonas JB, Kreissig I, Degenring RF, Kamppeter BA. Jonas JB, et al. Among authors: kreissig i. Br J Ophthalmol. 2005 Jan;89(1):122. doi: 10.1136/bjo.2004.050575. Br J Ophthalmol. 2005. PMID: 15615762 Free PMC article. No abstract available.

7

Factors influencing visual acuity after intravitreal triamcinolone acetonide as treatment of exudative age related macular degeneration.

Jonas JB, Kreissig I, Degenring RF. Jonas JB, et al. Among authors: kreissig i. Br J Ophthalmol. 2004 Dec;88(12):1557-62. doi: 10.1136/bjo.2003.039552. Br J Ophthalmol. 2004. PMID: 15548812 Free PMC article.

8

[Diffuse diabetic macular edema. Intraocular pressure after intravitreal triamcinolone acetonide].

Kreissig I, Degenring RF, Jonas JB. Kreissig I, et al. Ophthalmologe. 2005 Feb;102(2):153-7. doi: 10.1007/s00347-004-1074-5. Ophthalmologe. 2005. PMID: 15316734 Clinical Trial. German.

9

Exudative age-related macular degeneration treated by intravitreal triamcinolone acetonide. A prospective comparative nonrandomized study.

Jonas JB, Degenring RF, Kreissig I, Friedemann T, Akkoyun I. Jonas JB, et al. Among authors: kreissig i. Eye (Lond). 2005 Feb;19(2):163-70. doi: 10.1038/sj.eye.6701438. Eye (Lond). 2005. PMID: 15218517 Clinical Trial.

10

Branch retinal vein occlusion treated by intravitreal triamcinolone acetonide.

Jonas JB, Akkoyun I, Kamppeter B, Kreissig I, Degenring RF. Jonas JB, et al. Among authors: kreissig i. Eye (Lond). 2005 Jan;19(1):65-71. doi: 10.1038/sj.eye.6701395. Eye (Lond). 2005. PMID: 15105817 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results